Compare SCLX & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCLX | WKHS |
|---|---|---|
| Founded | 2011 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.4M | 31.8M |
| IPO Year | 2020 | 2008 |
| Metric | SCLX | WKHS |
|---|---|---|
| Price | $3.45 | $2.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.5K | ★ 62.6K |
| Earning Date | 11-13-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 86.92 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,253,000.00 | $763,173.00 |
| Revenue This Year | $118.16 | $61.80 |
| Revenue Next Year | $186.31 | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.79 | $0.53 |
| 52 Week High | $27.00 | $11.80 |
| Indicator | SCLX | WKHS |
|---|---|---|
| Relative Strength Index (RSI) | 22.30 | 45.29 |
| Support Level | N/A | $2.81 |
| Resistance Level | $5.60 | $3.56 |
| Average True Range (ATR) | 0.37 | 0.13 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 0.93 | 30.98 |
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.